Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide

We report a 34‐year‐old woman with recurrent gestational trophoblastic neoplasia (GTN) who showed hypersensitivity to etoposide. Computed tomography (CT) revealed a 32‐mm solid mass in the right lung and a 101‐mm cystic mass with solid components in the left side of the liver. The patient's ser...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of obstetrics and gynaecology research 2021-10, Vol.47 (10), p.3737-3741
Hauptverfasser: Yamaguchi, Noriko, Hamada, Yoshinobu, Inagaki, Risa, Nemoto, Kohei, Yoshitomi, Hideyuki, Takakura, Satoshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3741
container_issue 10
container_start_page 3737
container_title The journal of obstetrics and gynaecology research
container_volume 47
creator Yamaguchi, Noriko
Hamada, Yoshinobu
Inagaki, Risa
Nemoto, Kohei
Yoshitomi, Hideyuki
Takakura, Satoshi
description We report a 34‐year‐old woman with recurrent gestational trophoblastic neoplasia (GTN) who showed hypersensitivity to etoposide. Computed tomography (CT) revealed a 32‐mm solid mass in the right lung and a 101‐mm cystic mass with solid components in the left side of the liver. The patient's serum human chorionic gonadotropin (HCG) level was 689 439 mIU/mL. After eight cycles of combined paclitaxel 175 mg/m2 on day 1, ifosfamide 1 g/m2 on days 2–5, and cisplatin 20 mg/m2 on days 2–5 (TIP) every 3 weeks, the serum HCG level decreased to 2.4 mIU/mL. CT scan revealed disappearance of the lung tumor and significant reduction in the solid components of the liver tumor. Then, left hemihepatectomy was performed. After 3 months, there was no evidence of the disease, and the serum HCG level normalized. Thus, TIP chemotherapy, followed by residual mass resection, might be effective for methotrexate‐resistant GTN.
doi_str_mv 10.1111/jog.14945
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2578599356</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2578599356</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3215-c9e9da5f7a7ca75bf218873ed643aa50a109bc04876423a925cb14947ae9315b3</originalsourceid><addsrcrecordid>eNp1kcFO3DAQhqOqlUppD30DS5wqEbCTOI6PFSrQColD23M0cSYbr7xx8Hh32RuPwHvxFjwJXrbiVmuksTTf_3vGk2VfBT8T6Zwv_eJMVLqS77IjUVUq50rW79O9rETecFV_zD4RLTkXSovmKHv6vTYGiYa1YwRuAwtkMSDEFU6RbW0c2QzG2Qj36E6ZHTwNsLI9njKYemYszQ6inVgKSGi0b7oVxtEnr3uI-PzwGJAsRUjVBaYcrZ_Apbf8PPrOAUVr2IQ-2ZEFth0963GDzs_Ys3E3YyCcyEa7sXHHUodm78CiZxj97Cm19Dn7MIAj_PIvH2d_L3_8ubjOb26vfl58v8lNWQiZG426BzkoUAaU7IZCNI0qsa-rEkByEFx3hleNqquiBF1I0-2_VAHqUsiuPM5ODr5z8HfrNEy79OuQpqG2kKqRWpeyTtS3A2WCJwo4tHOwKwi7VvB2v6ukWrSvu0rs-YHdWoe7_4Ptr9urg-IFhzieLw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2578599356</pqid></control><display><type>article</type><title>Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide</title><source>Wiley Online Library All Journals</source><creator>Yamaguchi, Noriko ; Hamada, Yoshinobu ; Inagaki, Risa ; Nemoto, Kohei ; Yoshitomi, Hideyuki ; Takakura, Satoshi</creator><creatorcontrib>Yamaguchi, Noriko ; Hamada, Yoshinobu ; Inagaki, Risa ; Nemoto, Kohei ; Yoshitomi, Hideyuki ; Takakura, Satoshi</creatorcontrib><description>We report a 34‐year‐old woman with recurrent gestational trophoblastic neoplasia (GTN) who showed hypersensitivity to etoposide. Computed tomography (CT) revealed a 32‐mm solid mass in the right lung and a 101‐mm cystic mass with solid components in the left side of the liver. The patient's serum human chorionic gonadotropin (HCG) level was 689 439 mIU/mL. After eight cycles of combined paclitaxel 175 mg/m2 on day 1, ifosfamide 1 g/m2 on days 2–5, and cisplatin 20 mg/m2 on days 2–5 (TIP) every 3 weeks, the serum HCG level decreased to 2.4 mIU/mL. CT scan revealed disappearance of the lung tumor and significant reduction in the solid components of the liver tumor. Then, left hemihepatectomy was performed. After 3 months, there was no evidence of the disease, and the serum HCG level normalized. Thus, TIP chemotherapy, followed by residual mass resection, might be effective for methotrexate‐resistant GTN.</description><identifier>ISSN: 1341-8076</identifier><identifier>EISSN: 1447-0756</identifier><identifier>DOI: 10.1111/jog.14945</identifier><language>eng</language><publisher>Kyoto, Japan: John Wiley &amp; Sons Australia, Ltd</publisher><subject>Chemotherapy ; Chorionic gonadotropin ; Cisplatin ; Computed tomography ; Etoposide ; Gonadotropins ; HCG ; Hypersensitivity ; hypersensitivity reactions to etoposide ; Ifosfamide ; Liver ; Methotrexate ; methotrexate‐resistant GTN ; Paclitaxel ; Patients ; Pituitary (anterior) ; surgical resection ; TIP therapy</subject><ispartof>The journal of obstetrics and gynaecology research, 2021-10, Vol.47 (10), p.3737-3741</ispartof><rights>2021 Japan Society of Obstetrics and Gynecology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3215-c9e9da5f7a7ca75bf218873ed643aa50a109bc04876423a925cb14947ae9315b3</citedby><cites>FETCH-LOGICAL-c3215-c9e9da5f7a7ca75bf218873ed643aa50a109bc04876423a925cb14947ae9315b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjog.14945$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjog.14945$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27923,27924,45573,45574</link.rule.ids></links><search><creatorcontrib>Yamaguchi, Noriko</creatorcontrib><creatorcontrib>Hamada, Yoshinobu</creatorcontrib><creatorcontrib>Inagaki, Risa</creatorcontrib><creatorcontrib>Nemoto, Kohei</creatorcontrib><creatorcontrib>Yoshitomi, Hideyuki</creatorcontrib><creatorcontrib>Takakura, Satoshi</creatorcontrib><title>Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide</title><title>The journal of obstetrics and gynaecology research</title><description>We report a 34‐year‐old woman with recurrent gestational trophoblastic neoplasia (GTN) who showed hypersensitivity to etoposide. Computed tomography (CT) revealed a 32‐mm solid mass in the right lung and a 101‐mm cystic mass with solid components in the left side of the liver. The patient's serum human chorionic gonadotropin (HCG) level was 689 439 mIU/mL. After eight cycles of combined paclitaxel 175 mg/m2 on day 1, ifosfamide 1 g/m2 on days 2–5, and cisplatin 20 mg/m2 on days 2–5 (TIP) every 3 weeks, the serum HCG level decreased to 2.4 mIU/mL. CT scan revealed disappearance of the lung tumor and significant reduction in the solid components of the liver tumor. Then, left hemihepatectomy was performed. After 3 months, there was no evidence of the disease, and the serum HCG level normalized. Thus, TIP chemotherapy, followed by residual mass resection, might be effective for methotrexate‐resistant GTN.</description><subject>Chemotherapy</subject><subject>Chorionic gonadotropin</subject><subject>Cisplatin</subject><subject>Computed tomography</subject><subject>Etoposide</subject><subject>Gonadotropins</subject><subject>HCG</subject><subject>Hypersensitivity</subject><subject>hypersensitivity reactions to etoposide</subject><subject>Ifosfamide</subject><subject>Liver</subject><subject>Methotrexate</subject><subject>methotrexate‐resistant GTN</subject><subject>Paclitaxel</subject><subject>Patients</subject><subject>Pituitary (anterior)</subject><subject>surgical resection</subject><subject>TIP therapy</subject><issn>1341-8076</issn><issn>1447-0756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kcFO3DAQhqOqlUppD30DS5wqEbCTOI6PFSrQColD23M0cSYbr7xx8Hh32RuPwHvxFjwJXrbiVmuksTTf_3vGk2VfBT8T6Zwv_eJMVLqS77IjUVUq50rW79O9rETecFV_zD4RLTkXSovmKHv6vTYGiYa1YwRuAwtkMSDEFU6RbW0c2QzG2Qj36E6ZHTwNsLI9njKYemYszQ6inVgKSGi0b7oVxtEnr3uI-PzwGJAsRUjVBaYcrZ_Apbf8PPrOAUVr2IQ-2ZEFth0963GDzs_Ys3E3YyCcyEa7sXHHUodm78CiZxj97Cm19Dn7MIAj_PIvH2d_L3_8ubjOb26vfl58v8lNWQiZG426BzkoUAaU7IZCNI0qsa-rEkByEFx3hleNqquiBF1I0-2_VAHqUsiuPM5ODr5z8HfrNEy79OuQpqG2kKqRWpeyTtS3A2WCJwo4tHOwKwi7VvB2v6ukWrSvu0rs-YHdWoe7_4Ptr9urg-IFhzieLw</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Yamaguchi, Noriko</creator><creator>Hamada, Yoshinobu</creator><creator>Inagaki, Risa</creator><creator>Nemoto, Kohei</creator><creator>Yoshitomi, Hideyuki</creator><creator>Takakura, Satoshi</creator><general>John Wiley &amp; Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>202110</creationdate><title>Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide</title><author>Yamaguchi, Noriko ; Hamada, Yoshinobu ; Inagaki, Risa ; Nemoto, Kohei ; Yoshitomi, Hideyuki ; Takakura, Satoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3215-c9e9da5f7a7ca75bf218873ed643aa50a109bc04876423a925cb14947ae9315b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Chemotherapy</topic><topic>Chorionic gonadotropin</topic><topic>Cisplatin</topic><topic>Computed tomography</topic><topic>Etoposide</topic><topic>Gonadotropins</topic><topic>HCG</topic><topic>Hypersensitivity</topic><topic>hypersensitivity reactions to etoposide</topic><topic>Ifosfamide</topic><topic>Liver</topic><topic>Methotrexate</topic><topic>methotrexate‐resistant GTN</topic><topic>Paclitaxel</topic><topic>Patients</topic><topic>Pituitary (anterior)</topic><topic>surgical resection</topic><topic>TIP therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamaguchi, Noriko</creatorcontrib><creatorcontrib>Hamada, Yoshinobu</creatorcontrib><creatorcontrib>Inagaki, Risa</creatorcontrib><creatorcontrib>Nemoto, Kohei</creatorcontrib><creatorcontrib>Yoshitomi, Hideyuki</creatorcontrib><creatorcontrib>Takakura, Satoshi</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>The journal of obstetrics and gynaecology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamaguchi, Noriko</au><au>Hamada, Yoshinobu</au><au>Inagaki, Risa</au><au>Nemoto, Kohei</au><au>Yoshitomi, Hideyuki</au><au>Takakura, Satoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide</atitle><jtitle>The journal of obstetrics and gynaecology research</jtitle><date>2021-10</date><risdate>2021</risdate><volume>47</volume><issue>10</issue><spage>3737</spage><epage>3741</epage><pages>3737-3741</pages><issn>1341-8076</issn><eissn>1447-0756</eissn><abstract>We report a 34‐year‐old woman with recurrent gestational trophoblastic neoplasia (GTN) who showed hypersensitivity to etoposide. Computed tomography (CT) revealed a 32‐mm solid mass in the right lung and a 101‐mm cystic mass with solid components in the left side of the liver. The patient's serum human chorionic gonadotropin (HCG) level was 689 439 mIU/mL. After eight cycles of combined paclitaxel 175 mg/m2 on day 1, ifosfamide 1 g/m2 on days 2–5, and cisplatin 20 mg/m2 on days 2–5 (TIP) every 3 weeks, the serum HCG level decreased to 2.4 mIU/mL. CT scan revealed disappearance of the lung tumor and significant reduction in the solid components of the liver tumor. Then, left hemihepatectomy was performed. After 3 months, there was no evidence of the disease, and the serum HCG level normalized. Thus, TIP chemotherapy, followed by residual mass resection, might be effective for methotrexate‐resistant GTN.</abstract><cop>Kyoto, Japan</cop><pub>John Wiley &amp; Sons Australia, Ltd</pub><doi>10.1111/jog.14945</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1341-8076
ispartof The journal of obstetrics and gynaecology research, 2021-10, Vol.47 (10), p.3737-3741
issn 1341-8076
1447-0756
language eng
recordid cdi_proquest_journals_2578599356
source Wiley Online Library All Journals
subjects Chemotherapy
Chorionic gonadotropin
Cisplatin
Computed tomography
Etoposide
Gonadotropins
HCG
Hypersensitivity
hypersensitivity reactions to etoposide
Ifosfamide
Liver
Methotrexate
methotrexate‐resistant GTN
Paclitaxel
Patients
Pituitary (anterior)
surgical resection
TIP therapy
title Successful salvage treatment with paclitaxel, ifosfamide, and cisplatin in a patient with methotrexate‐resistant gestational trophoblastic neoplasia who developed hypersensitivity reaction to etoposide
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T14%3A42%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20salvage%20treatment%20with%20paclitaxel,%20ifosfamide,%20and%20cisplatin%20in%20a%20patient%20with%20methotrexate%E2%80%90resistant%20gestational%20trophoblastic%20neoplasia%20who%20developed%20hypersensitivity%20reaction%20to%20etoposide&rft.jtitle=The%20journal%20of%20obstetrics%20and%20gynaecology%20research&rft.au=Yamaguchi,%20Noriko&rft.date=2021-10&rft.volume=47&rft.issue=10&rft.spage=3737&rft.epage=3741&rft.pages=3737-3741&rft.issn=1341-8076&rft.eissn=1447-0756&rft_id=info:doi/10.1111/jog.14945&rft_dat=%3Cproquest_cross%3E2578599356%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2578599356&rft_id=info:pmid/&rfr_iscdi=true